Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axis

References

• Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2010;24(1):35–63. doi:10.1016/j.hoc.2009.11.008
   PubMed Web of Science ®Google Scholar
• Saleh K, Khalifeh-Saleh N, Kourie HR. Acute myeloid leukemia transformed to a targetable disease. Future Oncol. 2020;16(14):961–972. doi:10.2217/fon-2019-0670
   PubMed Web of Science ®Google Scholar
• Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481–3485. doi:10.1182/blood-2005-09-3724
   PubMed Web of Science ®Google Scholar
• Stolzel F, Stölzel F, Mohr B, et al. Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J. 2016;6:e386), doi:10.1038/bcj.2015.114
   PubMed Web of Science ®Google Scholar
• Stanchina M, Soong D, Zheng-Lin B, et al. Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers (Basel). 2020;12(11).
   Web of Science ®Google Scholar
• Mukherjee S, Sekeres MA. Novel therapies in acute myeloid leukemia. Semin Oncol Nurs. 2019;35(6):150955), doi:10.1016/j.soncn.2019.150955
   PubMed Web of Science ®Google Scholar
• Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol. 2017;14(8):992–999. doi:10.1080/15476286.2016.1220473
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6), doi:10.1186/s12943-018-0934-6
   PubMed Web of Science ®Google Scholar
• Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19(1):30), doi:10.1186/s12943-020-1135-7
   PubMed Web of Science ®Google Scholar
• Liu Y, Cheng Z, Pang Y, et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol. 2019;12(1):51), doi:10.1186/s13045-019-0734-5
   PubMedGoogle Scholar
• Xue F, Li M, Liu Y, et al. Circ_0035381 regulates acute myeloid leukemia development by modulating YWHAZ expression via adsorbing miR-582-3p. Biochem Genet. 2023;61(1):354–371. doi:10.1007/s10528-022-10244-1
   PubMed Web of Science ®Google Scholar
• Hu Q, Gu Y, Chen S, et al. Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p/HDGF axis. Aging (Albany NY). 2020;13(1):1120–1131.
   PubMedGoogle Scholar
• Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene. 2010;29(15):2161–2164. doi:10.1038/onc.2010.59
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–379. doi:10.1146/annurev-biochem-060308-103103
   PubMed Web of Science ®Google Scholar
• Mo YY. MicroRNA regulatory networks and human disease. Cell Mol Life Sci. 2012;69(21):3529–3531. doi:10.1007/s00018-012-1123-1
   PubMed Web of Science ®Google Scholar
• Wang X, Chen H, Bai J, et al. MicroRNA: an important regulator in acute myeloid leukemia. Cell Biol Int. 2017;41(9):936–945. doi:10.1002/cbin.10770
   PubMed Web of Science ®Google Scholar
• Wang G, Yu X, Xia J, et al. MicroRNA-9 restrains the sharp increase and boost apoptosis of human acute myeloid leukemia cells by adjusting the Hippo/YAP signaling pathway. Bioengineered. 2021;12(1):2906–2914. doi:10.1080/21655979.2021.1915727
   PubMed Web of Science ®Google Scholar
• Shang Z, Ming X, Wu J, et al. Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR-625-5p/SOX12 axis. Hematol Oncol. 2021;39(4):539–548. doi:10.1002/hon.2895
   PubMed Web of Science ®Google Scholar
• Tian C, Zhang L, Li X, et al. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Cancer Biomark. 2018;22(2):209–215. doi:10.3233/CBM-170657
   PubMed Web of Science ®Google Scholar
• Ke S, Li R-c, Lu J, et al. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2. Int J Hematol. 2017;106(2):258–265. doi:10.1007/s12185-017-2232-2
   PubMed Web of Science ®Google Scholar
• Li Q, Luan Q, Zhu H, et al. Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774/miR-192-5p/ULK1 ceRNA pathway. Biochem Biophys Res Commun. 2021;551:78–85. doi:10.1016/j.bbrc.2021.02.058
   PubMed Web of Science ®Google Scholar
• Wang J, Liu ZH, Yu LJ. Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia. Eur Rev Med Pharmacol Sci. 2019;23(17):7498–7509.
   PubMed Web of Science ®Google Scholar
• Chang W, et al. Circ-SFMBT2 facilitates the malignant growth of acute myeloid leukemia cells by modulating miR-582-3p/ZBTB20 pathway. Histol Histopathol. 2022;37(2):137–149.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs Act as miRNA Sponges. Adv Exp Med Biol. 2018;1087:67–79. doi:10.1007/978-981-13-1426-1_6
   PubMed Web of Science ®Google Scholar
• Polyatskin IL, Artemyeva AS, Krivolapov YA. Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition): lymphoid tumors. Arkh Patol. 2019;81(3):59–65. doi:10.17116/patol20198103159
   PubMedGoogle Scholar
• Patop IL, Kadener S. circRNAs in Cancer. Curr Opin Genet Dev. 2018;48:121–127.
   PubMed Web of Science ®Google Scholar
• Zhu LP, He YJ, Hou JC, et al. The role of circRNAs in cancers. Biosci Rep. 2017;37(5). doi:10.1042/BSR20170750
   Web of Science ®Google Scholar
• Arnaiz E, Sole C, Manterola L, et al. CircRNAs and cancer: Biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–99. doi:10.1016/j.semcancer.2018.12.002
   PubMed Web of Science ®Google Scholar
• Perez de Acha O, Rossi M, Gorospe M. Circular RNAs in blood malignancies. Front Mol Biosci. 2020;7:109, doi:10.3389/fmolb.2020.00109
   PubMed Web of Science ®Google Scholar
• Xiao Y, Ming X, Wu J. Hsa_circ_0002483 regulates miR-758-3p/MYC axis to promote acute myeloid leukemia progression. Hematol Oncol. 2021;39(2):243–253. doi:10.1002/hon.2829
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng F. Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis. Bioengineered. 2021;12(1):7704–7713. doi:10.1080/21655979.2021.1982310
   PubMed Web of Science ®Google Scholar
• Zhang S. The characteristics of circRNA as competing endogenous RNA in pathogenesis of acute myeloid leukemia. BMC Cancer. 2021;21(1):277), doi:10.1186/s12885-021-08029-7
   PubMed Web of Science ®Google Scholar
• He C, Luo B, Jiang N, et al. Oncomir or antioncomiR: role of miRNAs in acute myeloid leukemia. Leuk Lymphoma. 2019;60(2):284–294. doi:10.1080/10428194.2018.1480769
   PubMed Web of Science ®Google Scholar
• Fu S, et al. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3. Biosci Rep. 2021;41(9).
   Web of Science ®Google Scholar
• Wang H, et al. LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth. Cell Cycle. 2021: 1–11.
   Web of Science ®Google Scholar
• Dong R-F, Zhuang Y-J, Wang Y, et al. Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer. Kaohsiung J Med Sci. 2021;37(8):699–708. doi:10.1002/kjm2.12398
   PubMed Web of Science ®Google Scholar
• Cheng Y, Su Y, Wang S, et al. Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes (Basel). 2020;11(8).
   Web of Science ®Google Scholar
• Liu J, Jiang J, Hui X, et al. Mir-758-5p suppresses glioblastoma proliferation, migration and invasion by targeting ZBTB20. Cell Physiol Biochem. 2018;48(5):2074–2083. doi:10.1159/000492545
   PubMedGoogle Scholar
• Zhang Y, Zhou X, Cheng L, et al. ZBTB20 promotes cell migration and invasion of gastric cancer by inhibiting IκBα to induce NF-κB activation. Artif Cells Nanomed Biotechnol. 2019;47(1):3862–3872. doi:10.1080/21691401.2019.1670188
   PubMed Web of Science ®Google Scholar
• Xu X, Xie Q, Xie M, et al. Lncrna SNHG8 serves as an oncogene in breast cancer through miR-634/ZBTB20 axis. Cancer Manag Res. 2021;13:3017–3028. doi:10.2147/CMAR.S270128
   PubMed Web of Science ®Google Scholar